Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies

Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies

Abstract Background Many patients with polymyositis (PM) or dermatomyositis (DM) have circulating myositis-specific antibodies (MSAs). Interstitial lung disease (ILD) is a common manifestation of PM/DM, and it can even precede the onset of characteristic muscle or skin manifestations. Furthermore, t...

Full description

Bibliographic Details
Main Authors: Abhinav K. Misra, Nathan L. Wong, Terrance T. Healey, Edward V. Lally, Barry S. Shea
Format: Article
Language:English
Published: BMC 2021-11-01
Series:BMC Pulmonary Medicine
Subjects:
Interstitial lung disease
Myositis-specific antibodies
Polymyositis
Dermatomyositis
Online Access:https://doi.org/10.1186/s12890-021-01737-7

Internet

https://doi.org/10.1186/s12890-021-01737-7

Similar Items